{
    "response": "**Overall Treatment Decision:** Yes\u2014start\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intermittent pneumatic compression for DVT prophylaxis\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Right hemiparesis with reduced mobility Safe irrespective of final diagnosis\n\n*   **Treatment:** Physiotherapy and occupational therapy\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Improve gait instability and hemiparesis Prevents deconditioning\n\n*   **Treatment:** Symptomatic spasticity management (e.g., oral baclofen)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Right-sided spasticity causing impairment Improves comfort and function\n\n*   **Treatment:** Eye care for diplopia/ptosis (lubricants, occlusive patch/prism as needed)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Left oculomotor palsy with exposure/diplopia risk Prevents corneal injury and improves symptoms\n\n*   **Treatment:** Aspirin 300 mg load then 75\u2013100 mg daily\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Start only if MRI confirms ischaemic infarct Avoids worsening if cavernoma haemorrhage or tumour\n\n*   **Treatment:** High-intensity statin (e.g., atorvastatin 80 mg)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Indicated for confirmed ischaemic stroke for secondary prevention Not required for demyelinating or haemorrhagic causes\n\n*   **Treatment:** Anticoagulation\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Only if cardioembolic source identified Contraindicated in haemorrhagic/cavernoma aetiology\n\n*   **Treatment:** Intravenous methylprednisolone 1 g daily for 3\u20135 days\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Initiate if MRI/CSF support an acute demyelinating relapse Exclude active infection before steroids\n\n*   **Treatment:** Neurosurgical/Neuro-oncology referral\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Consider for cavernous malformation with symptomatic bleed or intrinsic tumor Management depends on imaging and clinical course\n\n*   **Treatment:** Long-term disease-modifying therapy for multiple sclerosis (if confirmed)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires diagnostic confirmation and risk\u2013benefit counselling Choice guided by MRI lesion load and prognostic factors\n\n\ntreatments = [{\"treatment\": \"Intermittent pneumatic compression for DVT prophylaxis\", \"timing\": \"Start Now\", \"reasons\": [\"Right hemiparesis with reduced mobility\", \"Safe irrespective of final diagnosis\"]}, {\"treatment\": \"Physiotherapy and occupational therapy\", \"timing\": \"Start Now\", \"reasons\": [\"Improve gait instability and hemiparesis\", \"Prevents deconditioning\"]}, {\"treatment\": \"Symptomatic spasticity management (e.g., oral baclofen)\", \"timing\": \"Start Now\", \"reasons\": [\"Right-sided spasticity causing impairment\", \"Improves comfort and function\"]}, {\"treatment\": \"Eye care for diplopia/ptosis (lubricants, occlusive patch/prism as needed)\", \"timing\": \"Start Now\", \"reasons\": [\"Left oculomotor palsy with exposure/diplopia risk\", \"Prevents corneal injury and improves symptoms\"]}, {\"treatment\": \"Aspirin 300 mg load then 75\\u2013100 mg daily\", \"timing\": \"Delay\", \"reasons\": [\"Start only if MRI confirms ischaemic infarct\", \"Avoids worsening if cavernoma haemorrhage or tumour\"]}, {\"treatment\": \"High-intensity statin (e.g., atorvastatin 80 mg)\", \"timing\": \"Delay\", \"reasons\": [\"Indicated for confirmed ischaemic stroke for secondary prevention\", \"Not required for demyelinating or haemorrhagic causes\"]}, {\"treatment\": \"Anticoagulation\", \"timing\": \"Delay\", \"reasons\": [\"Only if cardioembolic source identified\", \"Contraindicated in haemorrhagic/cavernoma aetiology\"]}, {\"treatment\": \"Intravenous methylprednisolone 1 g daily for 3\\u20135 days\", \"timing\": \"Delay\", \"reasons\": [\"Initiate if MRI/CSF support an acute demyelinating relapse\", \"Exclude active infection before steroids\"]}, {\"treatment\": \"Neurosurgical/Neuro-oncology referral\", \"timing\": \"Delay\", \"reasons\": [\"Consider for cavernous malformation with symptomatic bleed or intrinsic tumor\", \"Management depends on imaging and clinical course\"]}, {\"treatment\": \"Long-term disease-modifying therapy for multiple sclerosis (if confirmed)\", \"timing\": \"Delay\", \"reasons\": [\"Requires diagnostic confirmation and risk\\u2013benefit counselling\", \"Choice guided by MRI lesion load and prognostic factors\"]}]"
}